biosimilar

Dr Reddy’s launches Roche’s Avastin biosimilar in India

Read more

Mylan and Biocon launch first Trastuzumab Biosimilar, Ogivri, in Australia

Read more

Dr Reddy’s and TR-Pharm in agreement

Read more

Generic opportunities outweigh challenges emanating across emerging markets: ICRA

Read more

Intas launches RAZUMAB, the first biosimilar to Lucentis (ranibizumab)

Read more

Syngene seeks approval for IPO, files DRHP

Read more